PharmiWeb.com - Global Pharma News & Resources
30-Jan-2025

Calprotectin Testing Market Poised for Significant Growth, Projected to Reach USD 360.2 Billion by 2033 at a 6% of CAGR

Calprotectin Testing Devices Market

The global calprotectin testing market is witnessing strong growth, with an estimated valuation of USD 201.1 billion in 2023. The market is expected to expand at a compound annual growth rate (CAGR) of 6%, reaching USD 360.2 billion by 2033. This growth is primarily driven by the increasing prevalence of inflammatory bowel diseases (IBD) and the growing demand for non-invasive diagnostic tools.

As the number of IBD cases rises globally, the demand for calprotectin testing is surging, offering healthcare providers an effective means to diagnose and monitor chronic diseases. Patients are increasingly opting for non-invasive diagnostic options, which are both reliable and less disruptive to their daily lives. In addition, advancements in technology are further enhancing the accuracy and speed of calprotectin testing, with new devices enabling quicker results and improved disease detection.

The market’s growth is also fueled by rising awareness among healthcare providers and consumers about the benefits of calprotectin testing. As healthcare services continue to improve and expand, there is greater recognition of how these tests can reduce costs, manage chronic diseases more effectively, and help detect diseases at an early stage, thus improving patient outcomes.

Request a Sample of this Report Now: https://www.futuremarketinsights.com/report-sample#5245502d47422d3134353034

Key Takeaways:

  • The calprotectin testing market is expected to grow from USD 201.1 billion in 2023 to USD 360.2 billion by 2033, registering a CAGR of 6%.
  • The market is driven by the rising prevalence of inflammatory bowel disease (IBD) and a growing demand for non-invasive diagnostic tools.
  • Technological advancements are enhancing the accuracy, reliability, and speed of calprotectin testing.
  • Increased awareness and the rapid growth of the healthcare sector contribute to market opportunities, improving disease management and early detection.

Key Drivers of Market Growth

  • Prevalence of Inflammatory Bowel Disease (IBD): There is a rising incidence of IBD, which includes conditions like Crohn’s disease and ulcerative colitis, leading to increased demand for calprotectin testing as a diagnostic tool1.
  • Demand for Non-invasive Diagnostic Tools: Patients are increasingly favoring non-invasive methods for disease detection, making calprotectin testing a preferred choice for diagnosing chronic conditions1.
  • Advancements in Technology: Innovations in testing technology are enhancing the reliability and accuracy of calprotectin tests. New devices are being developed that can provide rapid results, further driving market adoption1.
  • Growing Awareness: Healthcare providers are increasing awareness among consumers regarding the benefits of calprotectin testing, which is creating new market opportunities1.
  • Expansion of the Healthcare Sector: The overall growth in the healthcare sector, characterized by improved services and technologies, supports the adoption of calprotectin testing. This testing helps in cost reduction, effective chronic disease management, and early symptom detection1.

Market Challenges

Despite its growth potential, the market faces challenges such as:

  • Limited Awareness: There is still a lack of awareness about calprotectin testing among some healthcare professionals and patients.
  • Quality Variability: The presence of low-standardized products can hinder market growth.
  • High Competition: The market is becoming increasingly competitive, which may affect pricing and accessibility1.

Other Essential Players in the Market are:

  • Actim Oy
  • Calpro AS
  • BÜHLMANN Laboratories AG
  • EagleBio
  • CerTest Biotec S.L.
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Boditech Med Inc.
  • Biohit Oyj
  • American Laboratory Products Company, Ltd.
  • DIAsource ImmunoAssays S.A
  • R-Biopharm AG.
  • Abbexa
  • AccuBio Tech Co., Ltd.
  • Screen Italia Srl.
  • Hangzhou Biotest Biotech Co., Ltd
  • Thermo Fisher Scientific
  • Epitope Diagnostics, Inc.
  • Elabscience Biotechnology Inc
  • Vitassay Healthcare, S.L.U.
  • Beckman Coulter Inc.
  • DiaSorin

Calprotectin Testing Market by Category

By Test Kits:

  • Calprotectin ELISA Test Kits
  • Calprotectin Rapid Testing Kits

By Sample:

  • Stool, Blood Serum/Plasma
  • Other Biological Samples

By Indication:

  • Irritable Bowel Syndrome
  • Ulcerative Colitis
  • Crohn’s Disease
  • Colorectal Cancer

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics

By Region:

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • The Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Editor Details

Last Updated: 30-Jan-2025